Attached files
| file | filename |
|---|---|
| 10-Q - China Yongxin Pharmaceuticals Inc. | v202631_10q.htm |
| EX-31.1 - China Yongxin Pharmaceuticals Inc. | v202631_ex31-1.htm |
| EX-31.2 - China Yongxin Pharmaceuticals Inc. | v202631_ex31-2.htm |
| EX-10.35 - China Yongxin Pharmaceuticals Inc. | v202631_ex10-35.htm |
| EX-10.34 - China Yongxin Pharmaceuticals Inc. | v202631_ex10-34.htm |
| EX-32.1 - China Yongxin Pharmaceuticals Inc. | v202631_ex32-1.htm |
Exhibit
32.2
Certification
of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C.
Section 1350,
as
adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
In
connection with the quarterly report of China Yongxin Pharmaceuticals Inc. (the
“Company”) on Form 10-Q for the quarter ending September 30, 2010, as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
the undersigned, in the capacities and on the date indicated below, hereby
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to his
knowledge:
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
/s/
Harry Zhang
|
|||
|
Harry
Zhang
|
|||
|
Chief
Financial Officer
|
|||
|
(Principal
Financial and Accounting Officer)
|
|||
|
November
22, 2010
|
The
foregoing certification is being furnished solely pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 and is not filed with the Securities and
Exchange Commission as part of the Form 10-Q or as a separate disclosure
document and is not incorporated by reference into any filing of China Yongxin
Pharmaceuticals Inc. under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, irrespective of any general
incorporation language contained in such filing. A signed original of this
written statement required by Section 906 has been provided to the Company
and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.